Listen on the go
CORRECT!
Next question
touchRESPIRATORY touchRESPIRATORY
Bronchiectasis
Watch Time: 8 mins

Francesco Blasi: Highlights from the World Bronchiectasis & NTM Conference

Share this Video
Copy Link
Published Online: Jul 28th 2022

touchRESPIRATORY were delighted to catch up with World Bronchiectasis & NTM Conference organising committee member, Prof. Francesco Blasi (University of Milan and IRCCS Fondazione Cà Granda Ospedale Maggiore, Milan, Italy) to discuss the take home messages from this year’s conference, the importance of young researchers in the Bronchiectasis & NTM community and what to look forward to at the 2023 conference.

The 5th World Bronchiectasis & NTM Conference was held in Prague from June 30th to July 2nd, 2022.

Questions 

  1. What makes the World Bronchiectasis & NTM Conference stand out from other congresses in this field? (0:23)
  2. What were the key take-home messages from this year’s conference? (2:21)
  3. Why do you consider it important to reserve a portion of the programme for the work of young researchers and clinicians? (3:52)
  4. Could you tell us a little about the 3rd European Bronchiectasis & NTM Workshop, which will be held in Milan in February 2023? (5:19)
  5. What were your personal highlights of this year’s conference? (6:35)

Disclosures: Francesco Blasi has nothing to disclose in relation to this video interview.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.

To find out more visit the conference website here.

Related Videos In Bronchiectasis
Bronchiectasis
Developed by Touch
The US Bronchiectasis and NTM Research Registry – aims and clinical developments: Mark Metersky, ATS 2023
Watch Time: 4 mins

The US Bronchiectasis and NTM Research Registry is a centralized database for the study of adult patients with non-cystic fibrosis bronchiectasis. In this interview Dr. Mark Metersky (UConn Health, Farmington, CT, USA) discusses the current challenges in the diagnosis and management of bronchiectasis and NTM, the aims of the registry and how it could impact […]

Bronchiectasis
Developed by Touch
A subgroup analysis of the WILLOW study – brensocatib in bronchiectasis by disease severity: Mark Metersky, ATS 2023
Watch Time: 4 mins

The phase 2 WILLOW trial (NCT03218917) investigated the efficacy, safety, tolerability, and PK of brensocatib in patients with non-cystic fibrosis bronchiectasis. We were delighted to speak with Dr Mark Metersky (UConn Health, Farmington, CT, USA) to learn more around his subgroup analysis looking at brensocatib efficacy by disease severity. The abstract ‘Outcomes of Patients With […]

Bronchiectasis
Developed by Touch
Stefano Aliberti: What to Expect from the 3rd European Bronchiectasis Workshop
Watch Time: 8 mins

touchRESPIRATORY caught up with World Bronchiectasis & NTM Conference organising committee member, Prof. Stefano Aliberti (Humanitas University, Milan and IRCCS Humanitas Research Hospital, Lombardia, Italy) to learn more around the upcoming conference taking place in Milan in 2023 and about Prof. Aliberti’s bid to become the European Respiratory Society Vice President. The 5th World Bronchiectasis […]

Trending In Bronchiectasis:

The US Bronchiectasis and NTM Research Registry – aims and clinical developments: Mark Metersky, ATS 2023
Bronchiectasis
    • Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72